Biotech Values

[SF Wolf]

Neurotrope Nears Breakthrough In New Alzheimer's Treatment

Apr. 3, 2017 4:46 PM ET

About: Neurotrope, Inc. (NTRP)
by: Sharon di Stefano


Sharon di Stefano

Biotech, healthcare, small-cap, special situations

(1,144 followers)

Summary
An extraordinary way to treat Alzheimer’s reaches Phase II.

Top line data expected in April 2017 in placebo controlled study of bryostatin-1 in 148 moderate to severe Alzheimer's patients.

Healing underlying causes versus symptoms can transform Alzheimer’s medicine.

Lead drug bryostatin, from a natural source, can be synthesized for manufacturing efficiency.

Common risks are translation of early results to larger trials, and competition.

Full article: 

https://seekingalpha.com/article/4059932-neurotrope-nears-breakthrough-new-alzheimers-treatment?auth_param=v6t5:1ce5bcr ;
 


         



|

More

Recs: 1     Views: 20